Science Explorer Interactive view Map
Company · Tucson · United States

NuvOx Pharma (United States)

nuvoxpharma.comROR OpenAlex
Research works
32
▲ 51% vs 2013–17
Citations
1.4k
44.0 per fractional work
Top-10% rate
10.3%
record average 16.5%
Open access
39%
world 28%

Not ranked overall: NuvOx Pharma (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at NuvOx Pharma (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Tumor Targeting, Reactive Oxygen Species, Drug Delivery, Oxidative Stress, Neuroprotection, Antioxidant and Cancer Therapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 33 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 33 words, with their numbers
  1. Immunotherapy3▲ 15×6 topics
  2. Tumor Targeting3▲ 69×3 topics
  3. Oxidative Stress3▲ 4.7×11 topics
  4. Reactive Oxygen Species2▲ 15×4 topics
  5. Drug Delivery2▲ 15×3 topics
  6. Inflammation2▲ 2.8×11 topics
  7. Nanoparticles2▲ 4.9×2 topics
  8. Neuroprotection2▲ 17×3 topics
  9. Antioxidant2▲ 8.7×9 topics
  10. Cancer Therapy2▲ 8.8×5 topics
  11. Antioxidants2▲ 13×3 topics
  12. Blood-Brain Barrier2▲ 81×2 topics
  13. Prognosis2▲ 16×2 topics
  14. Tumor Microenvironment2▲ 15×3 topics
  15. Epidemiology2▲ 1.25×2 topics
  16. Focused Ultrasound2▲ 176×1 topic
  17. Hemoglobin2▲ 174×1 topic
  18. Hyperthermia2▲ 89×1 topic
  19. Scavenger Receptor2▲ 174×1 topic
  20. Biomedical Applications2▲ 4.4×4 topics
  21. Cancer2▲ 3.4×9 topics
  22. Pathophysiology2▲ 17×1 topic
  23. Traumatic Brain Injury2▲ 45×1 topic
  24. Fluorescence Imaging1▲ 40×1 topic
  25. Gene Therapy1▲ 17×3 topics
  26. HIF-11▲ 63×1 topic
  27. Photothermal Therapy1▲ 53×1 topic
  28. Warburg Effect1▲ 63×1 topic
  29. Antioxidant Activity1▲ 6.4×2 topics
  30. Atherosclerosis1▲ 9.4×4 topics
  31. Polysaccharides1▲ 43×2 topics
  32. Tumor Regression1▲ 38×2 topics
  33. Biomarkers1▲ 5.2×3 topics

Which research topics does NuvOx Pharma (United States) publish most on?

By volume in 2022–2025: Traumatic Brain Injury and Neurovascular Disturbances, Cardiovascular and Diving-Related Complications, Hemoglobin structure and function and Cancer, Hypoxia, and Metabolism.

Traumatic Brain Injury and Neurovascular Disturbances: 0 fractional worksCardiovascular and Diving-Related Complications: 0 fractional worksHemoglobin structure and function: 0 fractional worksCancer, Hypoxia, and Metabolism: 0 fractional worksNanoplatforms for cancer theranostics: 0 fractional worksNeuroblastoma Research and Treatments: 0 fractional worksCAR-T cell therapy research: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksUltrasound and Hyperthermia Applications: 0 fractional worksRNA Interference and Gene Delivery: 0 fractional works
NeurologyPulmonary and Respiratory MedicineCell BiologyCancer Research3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Traumatic Brain Injury and Neurovascular Disturbances Neurology 0 works
  2. 2 Cardiovascular and Diving-Related Complications Pulmonary and Respiratory Medicine 0 works
  3. 3 Hemoglobin structure and function Cell Biology 0 works
  4. 4 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  5. 5 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
  6. 6 Neuroblastoma Research and Treatments Neurology 0 works
  7. 7 CAR-T cell therapy research Oncology 0 works
  8. 8 Cancer Immunotherapy and Biomarkers Oncology 0 works
  9. 9 Ultrasound and Hyperthermia Applications Biomedical Engineering 0 works
  10. 10 RNA Interference and Gene Delivery Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.4%not open60.6%

World: 28% of research is openly available.

with international co-authors22.8%domestic only77.2%

World: 19% is written across borders.

How has NuvOx Pharma (United States)'s research output changed?

Output in 2018–2022 was 51% higher than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tucson

All research institutions in Tucson

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.